Evidence supporting the use of: Triphala
For the health condition: Chronic Obstructive Pulmonary Disorder

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Traditional
Rating (out of 5): 1

Triphala, an Ayurvedic herbal formulation composed of three fruits (Amalaki, Bibhitaki, and Haritaki), is traditionally used for a variety of health conditions, mainly for digestive and general detoxification purposes. In the context of Chronic Obstructive Pulmonary Disease (COPD), its use is primarily grounded in traditional Ayurvedic medicine rather than robust scientific evidence. Classical Ayurvedic texts describe triphala as balancing for the doshas, especially kapha and vata, which are often implicated in respiratory disorders within this medical system. It is sometimes recommended as an adjunct for respiratory health due to its supposed anti-inflammatory, antioxidant, and mucolytic properties.

However, the scientific evidence specifically supporting triphala’s efficacy in COPD is very limited. A few preclinical studies have demonstrated anti-inflammatory and antioxidant effects in animal models or cell lines, which theoretically could be beneficial in COPD, a condition characterized by chronic inflammation and oxidative stress in the lungs. Some small human studies have explored triphala’s impact on general respiratory function or as part of broader Ayurvedic interventions, but these are sparse and generally of low methodological quality. No large-scale, rigorous clinical trials exist supporting its use specifically for COPD.

In summary, triphala’s use in COPD is primarily justified by traditional practice, with only minimal scientific support. Anyone considering its use should do so in consultation with a healthcare provider, especially since COPD is a serious and progressive disease requiring evidence-based management.

More about Triphala
More about Chronic Obstructive Pulmonary Disorder